arrow_back Back to App

Gio's Law: Epinephrine for Law Enforcement and Public Awareness

This law aims to enhance public safety by equipping law enforcement officers with life-saving medication (epinephrine) and training them in its administration. This means that in emergencies involving severe allergic reactions, help can arrive faster, potentially saving lives. Additionally, the law mandates a public awareness campaign about allergy symptoms and the role of first responders.
Key points
Law enforcement officers will be authorized to administer epinephrine in emergencies.
Officers will receive training on recognizing severe allergic reactions and administering the medication.
A public awareness campaign will educate citizens about allergy symptoms and the role of law enforcement.
The law allocates funds for medication purchase and training for fiscal years 2026-2030.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_4019
Sponsor: Rep. Gillen, Laura [D-NY-4]
Process start date: 2025-06-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Gio’s Law

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_4019.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-06-17.

What are the main provisions?

Key points include:

  • Law enforcement officers will be authorized to administer epinephrine in emergencies.
  • Officers will receive training on recognizing severe allergic reactions and administering the medication.
  • A public awareness campaign will educate citizens about allergy symptoms and the role of law enforcement.
  • The law allocates funds for medication purchase and training for fiscal years 2026-2030.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Gillen, Laura [D-NY-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on the Judiciary.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health Security